Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 11/20 | 1.00 |
| ▸ | MAPT | P10636 | 7/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 6/20 | 1.00 |
| ▸ | APP | P05067 | 4/20 | 1.00 |
| ▸ | SNCA | P37840 | 4/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 3/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 3/20 | 1.00 |
| ▸ | RBP4 | P02753 | 3/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | NR1I2 | O75469 | 1/20 | 1.00 |
| ▸ | USP2 | O75604 | 1/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.80 |
| ▸ | SLCO1B3 | Q9NPD5 | 2/20 | 0.80 |
| ▸ | SLCO1B1 | Q9Y6L6 | 2/20 | 0.80 |
| ▸ | LMNA | P02545 | 2/20 | 0.80 |
| ▸ | DRD3 | P35462 | 2/20 | 0.80 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.73 |
| ▸ | TP53 | P04637 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Retinol SCHEMBL15592 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTCYP3A4APPSNCA | |
| Retinol SCHEMBL1580302 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTCYP3A4APPSNCA | |
| Retinol SCHEMBL3113 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTCYP3A4APPSNCA | |
| Retinol SCHEMBL19660979 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTCYP3A4APPSNCA | |
| Retinol SCHEMBL3112 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTCYP3A4APPSNCA | |
| Retinol SCHEMBL1433566 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTCYP3A4APPSNCA | |
| Retinol SCHEMBL15593 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTCYP3A4APPSNCA | |
| Retinol SCHEMBL8360234 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTCYP3A4APPSNCA | |
| Retinol SCHEMBL14619410 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTCYP3A4APPSNCA | |
| Retinol SCHEMBL17226 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPTCYP3A4APPSNCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2082 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4731618-A2 | NOVEL CO-DRUG, CO-ADMINISTRATION, AND SEQUENTIAL ADMINISTRATION OF SELECTIVE TTR LIGAND AND C20-D3-RETINOL | The Trustees Of Columbia University In The City Of New York (US) | 2026-04-29 | — | — | EP | claimed |
| EP-4731204-A2 | SELECTIVE RBP4 ANTAGONIST AND C20-D3-RETINOL FOR TREATING MACULAR DEGENERATION, NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), AND GOUTY ARTHRITIS (GOUT) | The Trustees Of Columbia University In The City Of New York (US) | 2026-04-29 | — | — | EP | claimed |
| EP-4731619-A2 | NOVEL CO-DRUG, CO-ADMINISTRATION, AND SEQUENTIAL ADMINISTRATION OF BISPECIFIC RBP4/TTR LIGAND AND C20-D3-RETINOL | The Trustees Of Columbia University In The City Of New York (US) | 2026-04-29 | — | — | EP | claimed |
| EP-4626260-A2 | FERMENTATIVELY-PRODUCED RETINOID CONTAINING COMPOSITIONS, AND THE METHDOS OF MAKING AND USING THE SAME | DSM IP Assets B.V. (NL) | 2025-10-08 | — | — | EP | claimed |
| US-20250305024-A1 | RELATIVE POTENCY ASSAY FOR VIRAL VECTOR ENCODING ISOMEROHYDROLASES | SPARK THERAPEUTICS, INC. | 2025-10-02 | — | — | US | claimed |
| US-12359239-B2 | Relative potency assay for viral vector encoding isomerohydrolases | SPARK THERAPEUTICS, INC. (US) | 2025-07-15 | — | — | US | claimed |
| US-12329788-B2 | Synbiotic compositions | EVONIK OPERATIONS GMBH (DE) | 2025-06-17 | — | — | US | claimed |
| EP-3784807-B1 | SYNBIOTIC COMPOSITIONS | EVONIK OPERATIONS GMBH (DE) | 2025-06-04 | — | — | EP | claimed |
| US-12201956-B2 | Tunable process for silica capsules/spheres preparation and their use | PHARMA IN SILICA LABORATORIES INC. (CA) | 2025-01-21 | — | — | US | claimed |
| US-20250009633-A1 | PERSONAL CARE COMPOSITION | CONOPCO, INC., D/B/A UNILEVER (US) | 2025-01-09 | — | — | US | claimed |
| EP-1384482-A1 | EXTERNAL SKIN COMPOSITIONS | Kanebo, Limited (JP) | 2004-01-28 | — | — | EP | claimed |
| EP-1383379-A1 | RESTORATION OF CANCER-SUPPRESSING FUNCTIONS TO NEOPLASTIC CELLS THROUGH DNA HYPOMETHYLATION | SuperGen, Inc. (US) | 2004-01-28 | — | — | EP | claimed |
| WO-2002085400-A1 | COMPOSITIONS AND METHODS FOR REESTABLISHING GENE TRANSCRIPTION THROUGH INHIBITION OF DNA METHYLATION AND HISTONE DEACETYLASE | SUPERGEN, INC. (US) | 2002-10-31 | — | — | WO | claimed |
| WO-2002067681-A1 | RESTORE CANCER-SUPPRESSING FUNCTIONS TO NEOPLASTIC CELLS THROUGH DNA HYPOMETHYLATION | SUPERGEN, INC. (US) | 2002-09-06 | — | — | WO | claimed |
| US-20020114809-A1 | Restore cancer-suppressing functions to neoplastic cells through DNA hypomethylation | ASTEX PHARMACEUTICALS, INC. | 2002-08-22 | — | — | US | claimed |
| EP-0666076-B1 | Water in oil emulsion containing retinol | OREAL (FR) | 1998-12-23 | — | — | EP | claimed |
| US-5518914-A | Growth medium containing a complex of prealbumin, a retinoid and retinol-binding protein used to enhance B cell growth | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1996-05-21 | — | — | US | claimed |
| EP-0664821-A1 | LATENT STORE. | SABET HUSCHANG (DE) | 1995-08-02 | — | — | EP | claimed |
| WO-1994009081-A1 | LATENT STORE | SABET HUSCHANG (DE) | 1994-04-28 | — | — | WO | claimed |
| WO-1991001745-A1 | GROWTH FACTORS CONTAINING VITAMIN A OR OTHER RETINOIDS AND USES THEREOF | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1991-02-21 | — | — | WO | claimed |